Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer F-18-fluoromethylcholine

dc.contributor.authorHellberg S
dc.contributor.authorSilvola JMU
dc.contributor.authorKiugel M
dc.contributor.authorLiljenback H
dc.contributor.authorMetsala O
dc.contributor.authorViljanen T
dc.contributor.authorMetso J
dc.contributor.authorJauhiainen M
dc.contributor.authorSaukko P
dc.contributor.authorNuutila P
dc.contributor.authorYla-Herttuala S
dc.contributor.authorKnuuti J
dc.contributor.authorRoivainen A
dc.contributor.authorSaraste A
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kliininen fysiologia ja isotooppilääketiede|en=Clinical Physiology and Isotope Medicine|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=patologia ja oikeuslääketiede|en=Pathology and Forensic Medicine|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.40465558829
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code2607322
dc.contributor.organization-code2609830
dc.converis.publication-id3640506
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/3640506
dc.date.accessioned2022-10-27T11:57:25Z
dc.date.available2022-10-27T11:57:25Z
dc.description.abstract<p><b>Background: </b>Diabetes is a risk factor for atherosclerosis associated with oxidative stress, inflammation and cell proliferation. The purpose of this study was to evaluate arterial choline uptake and its relationship to atherosclerotic inflammation in diabetic and non-diabetic hypercholesterolemic mice.<b><br /></b><b>Methods: </b>Low-density lipoprotein-receptor deficient mice expressing only apolipoprotein B100, with or without type 2 diabetes caused by pancreatic overexpression of insulin-like growth factor II (IGF-II/LDLR<sup>−/−</sup>ApoB<sup>100/100</sup> and LDLR<sup>−/−</sup>ApoB<sup>100/100</sup>) were studied. Distribution kinetics of choline analogue <sup>18</sup>F-fluoromethylcholine (<sup>18</sup>F-FMCH) was assessed in vivo by positron emission tomography (PET) imaging. Then, aortic uptakes of <sup>18</sup>F-FMCH and glucose analogue <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG), were assessed ex vivo by gamma counting and autoradiography of tissue sections. The <sup>18</sup>F-FMCH uptake in atherosclerotic plaques was further compared with macrophage infiltration and the plasma levels of cytokines and metabolic markers. <br /><b>Results: </b>The aortas of all hypercholesterolemic mice showed large, macrophage-rich atherosclerotic plaques. The plaque burden and densities of macrophage subtypes were similar in diabetic and non-diabetic animals. The blood clearance of <sup>18</sup>F-FMCH was rapid. Both the absolute <sup>18</sup>F-FMCH uptake in the aorta and the aorta-to-blood uptake ratio were higher in diabetic than in non-diabetic mice. In autoradiography, the highest <sup>18</sup>F-FMCH uptake co-localized with macrophage-rich atherosclerotic plaques. <sup>18</sup>F-FMCH uptake in plaques correlated with levels of total cholesterol, insulin, C-peptide and leptin. In comparison with <sup>18</sup>F-FDG, <sup>18</sup>F-FMCH provided similar or higher plaque-to-background ratios in diabetic mice. <br /><b>Conclusions: </b>Type 2 diabetes enhances the uptake of choline that reflects inflammation in atherosclerotic plaques in mice. PET tracer <sup>18</sup>F-FMCH is a potential tool to study vascular inflammation associated with diabetes.</p>
dc.identifier.jour-issn1475-2840
dc.identifier.olddbid173090
dc.identifier.oldhandle10024/156184
dc.identifier.urihttps://www.utupub.fi/handle/11111/56082
dc.identifier.urnURN:NBN:fi-fe2021042715257
dc.language.isoen
dc.okm.affiliatedauthorHellberg, Sanna
dc.okm.affiliatedauthorSilvola, Johanna
dc.okm.affiliatedauthorKiugel, Max
dc.okm.affiliatedauthorLiljenbäck, Heidi
dc.okm.affiliatedauthorMetsälä, Olli
dc.okm.affiliatedauthorViljanen, Tapio
dc.okm.affiliatedauthorSaukko, Pekka
dc.okm.affiliatedauthorNuutila, Pirjo
dc.okm.affiliatedauthorKnuuti, Juhani
dc.okm.affiliatedauthorRoivainen, Anne
dc.okm.affiliatedauthorSaraste, Antti
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherBIOMED CENTRAL LTD
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumber26
dc.relation.doi10.1186/s12933-016-0340-6
dc.relation.ispartofjournalCardiovascular Diabetology
dc.relation.volume15
dc.source.identifierhttps://www.utupub.fi/handle/10024/156184
dc.titleType 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer F-18-fluoromethylcholine
dc.year.issued2016

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s12933-016-0340-6.pdf
Size:
1.99 MB
Format:
Adobe Portable Document Format
Description:
Publishers's PDF